BIO - Biome expects FY24 international sales revenue to grow 85%+ vs PCP (FY23 $459k)
COV - Cleo's Ovarian Cancer Blood Test Outperforms Current Clinical Benchmark
PER - PHASE IIB STUDY OF ATL1102 IN DMD COMPLETES RECRUITMENT
GTG - Launches Revolutionary geneType Test covering 100% Risk of Breast andOvarian Cancer
- Forums
- ASX - Day Trading
- Morning Trading May 29
Morning Trading May 29, page-12
-
- There are more pages in this discussion • 223 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)